ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 673,87
1,17%
DAX
18 001,60
0,54%
Brent Oil
83,115
-0,62%
Bitcoin
61 826,18
4,58%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Lexaria Bioscience Corporation (LEXX)

  7. Lexaria Bioscience Corporation (LEXX) Actualités

LEXX Lexaria Bioscience Corporation

3,06
0,06 (2,00%)
Dernière mise à jour : 17:46:51
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Lexaria Bioscience Corporation LEXX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,06 2,00% 3,06 17:46:51
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
3,05 2,93 3,14 3,00
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/3/202412:00EDGAR2Form DEF 14A - Other definitive proxy statements
01/3/202420:28EDGAR2Form 8-K - Current report
16/2/202422:30EDGAR2Form 8-K - Current report
16/2/202421:47EDGAR2Form D - Notice of Exempt Offering of Securities
14/2/202420:20EDGAR2Form SC 13D/A - General statement of acquisition of..
14/2/202418:00EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30/1/202419:51EDGAR2Form 8-K - Current report
24/1/202420:12EDGAR2Form 8-K - Current report
24/1/202419:33EDGAR2Form POS AM - Post-Effective amendments for registration..
18/1/202420:38EDGAR2Form S-8 - Securities to be offered to employees in employee..
12/1/202423:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/1/202414:30GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Proprietary..
10/1/202414:45IHNWGLP-1: Beyond Diabetes, a Blockbuster Horizon Beckons
09/1/202414:30GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Improves Delivery,..
08/1/202414:45IHNWExciting New Cures Possible from GLP-1 Diabetes, Weight-Loss..
04/1/202423:07EDGAR2Form 8-K - Current report
30/11/202322:14EDGAR2Form S-1 - General form for registration of securities under..
20/11/202323:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
03/11/202318:13EDGAR2Form 8-K - Current report
01/11/202318:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/11/202313:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
01/11/202313:30GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Expands Studies of..
31/10/202313:31GLOBELexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating..
30/10/202317:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202313:45IHNWCan Diabetes, Weight-Loss Drugs Get Even Better?
18/10/202318:25EDGAR2Form 8-K - Current report
16/10/202319:13EDGAR2Form 8-K - Current report
12/10/202321:57EDGAR2Form 8-K - Current report
03/10/202322:05EDGAR2Form 8-K - Current report
28/8/202320:50EDGAR2Form 8-K - Current report
28/7/202318:11EDGAR2Form 8-K - Current report
25/7/202320:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202319:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/7/202322:00EDGAR2Form 8-K - Current report
14/7/202320:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Dernières Valeurs Consultées

NASDAQ
LEXX
Lexaria Bioscience
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés